Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Monitoring Hyperkalemia Using Point-of-care AI-enabled ECG Device Among Patients With Chronic Kidney Disease Stages 3b-5 to Reduce Rate of Hyperkalemia - a Practical Randomized Clinical Trial

NCT06901960 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.

NCT NCT06901960
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06901960 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Monitoring Hyperkalemia Using Point-of-care AI-enabled ECG Device Among Patients With Chronic Kidney Disease Stages 3b-5 to Reduce Rate of Hyperkalemia - a Practical Randomized Clinical Trial
Lead sponsor
Peking University First Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
April 2, 2025
Completion date
December 31, 2026
Enrollment
1,066 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease (stages 3b-5)